SB 606 – Drug Pricing, Marketing & Regulation: Clinical Trials 

Author - Jack Scott (D-Altadena)

CHI Position - Watch

Summary - Bill amended and no longer applicable to CHI.  Would have required a pharmaceutical company that sells, delivers, offers for sale, or gives away pharmaceutical drugs in California to make publicly available the results of every completed clinical trial, except a phase I trial.

Status -